XTL Biopharmaceutica Stock Forecast - Simple Moving Average
| XTLB Stock | USD 0.95 0.11 10.19% |
XTL Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast XTL Biopharmaceutica stock prices and determine the direction of XTL Biopharmaceuticals Ltd's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of XTL Biopharmaceutica's historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, The RSI of XTL Biopharmaceutica's share price is at 51. This entails that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling XTL Biopharmaceutica, making its price go up or down. Momentum 51
Impartial
Oversold | Overbought |
Quarterly Earnings Growth (0.76) | Wall Street Target Price 30 |
Using XTL Biopharmaceutica hype-based prediction, you can estimate the value of XTL Biopharmaceuticals Ltd from the perspective of XTL Biopharmaceutica response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Moving Average forecasted value of XTL Biopharmaceuticals Ltd on the next trading day is expected to be 0.95 with a mean absolute deviation of 0.04 and the sum of the absolute errors of 2.33. XTL Biopharmaceutica after-hype prediction price | USD 1.06 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of XTL Biopharmaceutica to cross-verify your projections. XTL Biopharmaceutica Additional Predictive Modules
Most predictive techniques to examine XTL price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for XTL using various technical indicators. When you analyze XTL charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
XTL Biopharmaceutica Simple Moving Average Price Forecast For the 27th of January
Given 90 days horizon, the Simple Moving Average forecasted value of XTL Biopharmaceuticals Ltd on the next trading day is expected to be 0.95 with a mean absolute deviation of 0.04, mean absolute percentage error of 0, and the sum of the absolute errors of 2.33.Please note that although there have been many attempts to predict XTL Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that XTL Biopharmaceutica's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
XTL Biopharmaceutica Stock Forecast Pattern
| Backtest XTL Biopharmaceutica | XTL Biopharmaceutica Price Prediction | Buy or Sell Advice |
XTL Biopharmaceutica Forecasted Value
In the context of forecasting XTL Biopharmaceutica's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. XTL Biopharmaceutica's downside and upside margins for the forecasting period are 0.01 and 9.73, respectively. We have considered XTL Biopharmaceutica's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of XTL Biopharmaceutica stock data series using in forecasting. Note that when a statistical model is used to represent XTL Biopharmaceutica stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 109.0052 |
| Bias | Arithmetic mean of the errors | 0.0042 |
| MAD | Mean absolute deviation | 0.0394 |
| MAPE | Mean absolute percentage error | 0.0456 |
| SAE | Sum of the absolute errors | 2.327 |
Predictive Modules for XTL Biopharmaceutica
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as XTL Biopharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.XTL Biopharmaceutica After-Hype Price Density Analysis
As far as predicting the price of XTL Biopharmaceutica at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in XTL Biopharmaceutica or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of XTL Biopharmaceutica, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
XTL Biopharmaceutica Estimiated After-Hype Price Volatility
In the context of predicting XTL Biopharmaceutica's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on XTL Biopharmaceutica's historical news coverage. XTL Biopharmaceutica's after-hype downside and upside margins for the prediction period are 0.05 and 9.91, respectively. We have considered XTL Biopharmaceutica's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
XTL Biopharmaceutica is out of control at this time. Analysis and calculation of next after-hype price of XTL Biopharmaceuticals is based on 3 months time horizon.
XTL Biopharmaceutica Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as XTL Biopharmaceutica is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading XTL Biopharmaceutica backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with XTL Biopharmaceutica, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.15 | 8.78 | 0.00 | 0.03 | 10 Events / Month | 6 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.95 | 1.06 | 0.00 |
|
XTL Biopharmaceutica Hype Timeline
XTL Biopharmaceuticals is at this time traded for 0.95. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.03. XTL is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is expected to be very small, whereas the daily expected return is at this time at 0.15%. %. The volatility of related hype on XTL Biopharmaceutica is about 3990.91%, with the expected price after the next announcement by competition of 0.98. About 38.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 1.9. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. XTL Biopharmaceuticals recorded a loss per share of 0.9. The entity last dividend was issued on the 10th of February 2017. The firm had 1:5 split on the 10th of February 2017. Given the investment horizon of 90 days the next expected press release will be in about 10 days. Check out Historical Fundamental Analysis of XTL Biopharmaceutica to cross-verify your projections.XTL Biopharmaceutica Related Hype Analysis
Having access to credible news sources related to XTL Biopharmaceutica's direct competition is more important than ever and may enhance your ability to predict XTL Biopharmaceutica's future price movements. Getting to know how XTL Biopharmaceutica's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how XTL Biopharmaceutica may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CYCN | Cyclerion Therapeutics | 2.96 | 30 per month | 0.00 | (0.05) | 11.11 | (10.56) | 55.81 | |
| PLRZ | Polyrizon Ltd Ordinary | (0.28) | 9 per month | 6.08 | 0.12 | 11.50 | (14.22) | 149.99 | |
| VYNE | Vyne Therapeutics | 0.00 | 8 per month | 2.58 | 0.11 | 5.71 | (5.26) | 55.08 | |
| TCRT | Alaunos Therapeutics | (0.08) | 7 per month | 5.95 | 0 | 9.61 | (10.55) | 24.31 | |
| AIM | AIM ImmunoTech | 0.01 | 9 per month | 0.00 | (0.18) | 8.24 | (10.32) | 29.72 | |
| QNRX | Quoin Pharmaceuticals Ltd | (0.02) | 9 per month | 0.00 | (0.03) | 18.69 | (11.19) | 77.47 | |
| KTTA | Pasithea Therapeutics Corp | 0.01 | 11 per month | 7.56 | 0.07 | 16.67 | (12.50) | 137.41 | |
| KALA | Kala Pharmaceuticals | (0.36) | 7 per month | 0.00 | (0.04) | 12.28 | (11.76) | 59.48 | |
| RADX | Radiopharm Theranostics Limited | 0.00 | 0 per month | 8.09 | 0.04 | 7.44 | (9.23) | 193.18 | |
| ENSC | Ensysce Biosciences | (0.04) | 11 per month | 0.00 | (0.31) | 5.94 | (10.78) | 23.86 |
Other Forecasting Options for XTL Biopharmaceutica
For every potential investor in XTL, whether a beginner or expert, XTL Biopharmaceutica's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. XTL Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in XTL. Basic forecasting techniques help filter out the noise by identifying XTL Biopharmaceutica's price trends.XTL Biopharmaceutica Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with XTL Biopharmaceutica stock to make a market-neutral strategy. Peer analysis of XTL Biopharmaceutica could also be used in its relative valuation, which is a method of valuing XTL Biopharmaceutica by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
XTL Biopharmaceutica Market Strength Events
Market strength indicators help investors to evaluate how XTL Biopharmaceutica stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading XTL Biopharmaceutica shares will generate the highest return on investment. By undertsting and applying XTL Biopharmaceutica stock market strength indicators, traders can identify XTL Biopharmaceuticals Ltd entry and exit signals to maximize returns.
XTL Biopharmaceutica Risk Indicators
The analysis of XTL Biopharmaceutica's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in XTL Biopharmaceutica's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting xtl stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.37 | |||
| Semi Deviation | 5.02 | |||
| Standard Deviation | 8.53 | |||
| Variance | 72.83 | |||
| Downside Variance | 31.51 | |||
| Semi Variance | 25.2 | |||
| Expected Short fall | (5.77) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for XTL Biopharmaceutica
The number of cover stories for XTL Biopharmaceutica depends on current market conditions and XTL Biopharmaceutica's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that XTL Biopharmaceutica is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about XTL Biopharmaceutica's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
XTL Biopharmaceutica Short Properties
XTL Biopharmaceutica's future price predictability will typically decrease when XTL Biopharmaceutica's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of XTL Biopharmaceuticals Ltd often depends not only on the future outlook of the potential XTL Biopharmaceutica's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. XTL Biopharmaceutica's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.8 M | |
| Cash And Short Term Investments | 1.1 M |
Check out Historical Fundamental Analysis of XTL Biopharmaceutica to cross-verify your projections. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of XTL Biopharmaceutica. If investors know XTL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about XTL Biopharmaceutica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.76) | Earnings Share (0.90) | Revenue Per Share | Return On Assets | Return On Equity |
The market value of XTL Biopharmaceuticals is measured differently than its book value, which is the value of XTL that is recorded on the company's balance sheet. Investors also form their own opinion of XTL Biopharmaceutica's value that differs from its market value or its book value, called intrinsic value, which is XTL Biopharmaceutica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because XTL Biopharmaceutica's market value can be influenced by many factors that don't directly affect XTL Biopharmaceutica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between XTL Biopharmaceutica's value and its price as these two are different measures arrived at by different means. Investors typically determine if XTL Biopharmaceutica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, XTL Biopharmaceutica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.